Search results
Your search for process/pmg6 returned no results
Showing 1621 to 1635 of 2854 results for process
Showing 1621 to 1635 of 2854 results for process
Summary of the evidence on co-enzyme Q10 for mitochondrial disorders in children to inform local NHS planning and decision-making
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids .
approaches, include a suitable comparator, and use combined impact and process evaluations. Evidence on a range of outcomes is needed,...
(AI) purposes. All requests, without exception, are subject to an approval process, licensing arrangement and a fee (for international...
This guideline covers how to improve the health and wellbeing of employees, with a focus on organisational culture and the role of line managers.
This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant (TA640)
Evidence-based recommendations on treosulfan (Trecondi) with fludarabine for conditioning treatment before allogeneic haematopoietic stem cell transplant for malignant diseases in people for whom a reduced intensity regimen would be suitable.
Trabectedin for the treatment of advanced soft tissue sarcoma (TA185)
Evidence-based recommendations on trabectedin (Yondelis) for treating advanced soft tissue sarcoma in adults.
notes(if applicable) Why this is important: This guideline development process uses published summary data from trials in a...
What is the effectiveness of statin therapy in older people?
important: The UK population is ageing and atherosclerosis is an age-associated process. Few trials assessing cardiovascular outcomes...
clinicians and the patient. Health economic modelling is needed to inform this process. Source guidance details Comes from guidance...
Ventripoint Medical System Plus for measuring heart volume and function (MIB310)
February 2023: The medtech innovation briefing on Ventripoint Medical System Plus for measuring heart volume and function has been withdrawn as the company have withdrawn from the process.
Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for human epidermal growth factor receptor 2 (HER2)-positive, unresectable, locally advanced or metastatic breast cancer in adults who have had trastuzumab and a taxane.
NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma .
method and identify what support is needed for women during and after the process. It could also reduce the cost to the NHS of providing...